Oncology Blood Testing Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Oncology Blood Testing Market is anticipated to gain exponential industry growth over the given forecast period of 2022-2028.

Oncology blood testing is an innovative diagnostic technology that detects cancer early. For early detection of cancer, liquid biopsy has become a popular diagnostic tool. Unlike traditional invasive biopsies, liquid biopsies are less invasive than traditional biopsies by taking blood from the body of the suspected patient. Since cancer is a life-threatening disease, it can be cured only when diagnosed and treated in a timely manner. There are various oncology blood tests available on the market to screen for cancer cells in the blood. The main types of blood tests for diagnosing cancer include complete blood counts, blood protein tests, tumor marker tests, CTC-based tests, non-invasive prenatal tests, liquid biopsy assays, and test-based liquid biopsies.

Market Segments

By Type

• CBC (Complete Blood Count) Test
• Blood Protein Test
• Tumor Marker Test
• CTC (Circulating Tumor Cells) ? based Test
• NIPT (Non-Invasive Prenatal Testing) Test
• Liquid Biopsy Assays
• Exom-Based Liquid Biopsy

By Application

• Lung Cancer
• Breast Cancer
• Colon Cancer
• Melanoma
• Ovarian Cancer
• Gastro-Intestinal Stromal Tumor (GIST)

Key Players

• Guardant Health Inc.
• Trovagene Inc.
• Genomic Health Inc.
• Foundation Medicine Inc.
• Exosome Diagnostics
• Pathway Genomics Corporation

Scope of the Report

The research study analyzes the global Oncology Blood Testing industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Oncology Blood Testing Market Report

1. What was the Oncology Blood Testing Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Oncology Blood Testing Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Oncology Blood Testing Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.